1. Home
  2. FFWM vs ALT Comparison

FFWM vs ALT Comparison

Compare FFWM & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFWM
  • ALT
  • Stock Information
  • Founded
  • FFWM 1990
  • ALT 1997
  • Country
  • FFWM United States
  • ALT United States
  • Employees
  • FFWM N/A
  • ALT N/A
  • Industry
  • FFWM Major Banks
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFWM Finance
  • ALT Health Care
  • Exchange
  • FFWM Nasdaq
  • ALT Nasdaq
  • Market Cap
  • FFWM 378.0M
  • ALT 397.4M
  • IPO Year
  • FFWM 2014
  • ALT N/A
  • Fundamental
  • Price
  • FFWM $5.21
  • ALT $4.16
  • Analyst Decision
  • FFWM Buy
  • ALT Strong Buy
  • Analyst Count
  • FFWM 4
  • ALT 6
  • Target Price
  • FFWM $7.25
  • ALT $18.20
  • AVG Volume (30 Days)
  • FFWM 768.6K
  • ALT 11.4M
  • Earning Date
  • FFWM 07-31-2025
  • ALT 08-07-2025
  • Dividend Yield
  • FFWM N/A
  • ALT N/A
  • EPS Growth
  • FFWM N/A
  • ALT N/A
  • EPS
  • FFWM N/A
  • ALT N/A
  • Revenue
  • FFWM $113,564,000.00
  • ALT $20,000.00
  • Revenue This Year
  • FFWM $182.35
  • ALT N/A
  • Revenue Next Year
  • FFWM $7.79
  • ALT $1,557,547.90
  • P/E Ratio
  • FFWM N/A
  • ALT N/A
  • Revenue Growth
  • FFWM N/A
  • ALT N/A
  • 52 Week Low
  • FFWM $4.42
  • ALT $2.90
  • 52 Week High
  • FFWM $8.52
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • FFWM 45.17
  • ALT 40.54
  • Support Level
  • FFWM $5.04
  • ALT $4.07
  • Resistance Level
  • FFWM $5.63
  • ALT $4.79
  • Average True Range (ATR)
  • FFWM 0.19
  • ALT 0.45
  • MACD
  • FFWM -0.00
  • ALT -0.10
  • Stochastic Oscillator
  • FFWM 29.17
  • ALT 28.16

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: